At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...
Proscia sells digital pathology software and artificial intelligence tools to pharmaceutical companies and diagnostic ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...
Seventy-one University of Kentucky students will present their research at the National Conference on Undergraduate Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results